Giuseppe Lippi/LinkedIn
Oct 10, 2025, 03:09
Giuseppe Lippi: We Show Here That Red Light Therapy Offers Promise in High-Risk Patients
Giuseppe Lippi, Dean of Medicine at the University of Verona, shared on LinkedIn:
”We show here that red light therapy offers promise in high-risk patients where conventional anticoagulation is limited by bleeding risk.
Fan BE, Pasalic L, Lippi G, Hew YY, Favaloro EJ. Red Light Therapy in Thrombosis and Hemostasis. Semin Thromb Hemost. 2025 Oct 8. doi: 10.1055/a-2717-5157. Epub ahead of print.”
Read the full article in Seminars in Thrombosis and Hemostasis.
Article: Red Light Therapy in Thrombosis and Hemostasis
Authors: Bingwen Eugene Fan , Leonardo Pasalic, Giuseppe Lippi , Yu Yue Hew, Emmanuel J. Favaloro
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Dec 15, 2025, 15:58Khaled Musallam Applauds Hatoon Ezzat’s Leadership and Healthcare Advances in Saudi Arabia
-
Dec 15, 2025, 12:46Deborah Ebert Long on Hemophilia Care: Progress, Possibility, and the Power of Listening
-
Dec 15, 2025, 12:34Nathan Connell on Conversion from Eptacog Alfa to Beta
-
Dec 15, 2025, 12:17Danny Hsu on Interdisciplinary Toolkit for Gynecologic Bleeding on Anticoagulation
-
Dec 15, 2025, 12:08Ted Roh: A Historic Milestone for Indonesia’s Health Innovation
-
Dec 15, 2025, 11:28Wolfgang Miesbach Shares Insights from Davide Matino’s Presentation on Marstacimab at ASH25
-
Dec 15, 2025, 11:12Tushar Pandey Awarded for His Enourmous Contribution to Hematology
-
Dec 15, 2025, 11:07DISTRO: Vidya Rajbhoj on AI and Digital Technology to Improve Stroke Rehabilitation
-
Dec 15, 2025, 11:00Ischemic Stroke, AF and Atherosclerotis: Amira Khater on Sufficiency of Anticoagulant Monotherapy